Radboud University Medical Center Becomes First Hospital in the Netherlands to Win HIMSS Stage 7 Award

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, has awarded Radboud university medical center with the Stage 7 Award, making it the first HIMSS Stage 7 hospital in the Netherlands and the third in Europe.

The hospital, which has 953 beds, joins the University Medical Centre Hamburg-Eppendorf in Germany and the Hospital de Dénia-Marina Salud in Spain in the highest stage of the European EMR Adoption Model (EMRAM) developed by HIMSS.

The Netherlands enjoy a high number of Stage 6 awarded hospitals, which consolidates this country as one of the European leaders in ehealth. Beside Radboudumc, as of today, 10 Dutch hospitals and university medical centers have achieved Stage 6. Across Europe there are more than 50 hospitals recognized in the Stage 6 category.

EMRAM has been adapted to meet the needs of European healthcare institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the aim of reaching Stage 7, which represents a superior electronic patient record environment.

Hospitals that reach Stage 7 support the true sharing and use of patient data to improve process performance, quality of care and patient safety. Uwe Buddrus, senior consultant at HIMSS Analytics Europe, said: "Radboudumc is only the third hospital in Europe to achieve the prestigious HIMSS EMRAM Stage 7 Award and the first within two years during which many European hospitals - more than 1100 in Europe, 62 of which in The Netherlands - participated in the EMRAM evaluation. I am very happy that HIMSS has identified another best practice example in Europe, which I am sure will stimulate many other hospitals on their journey towards improving healthcare delivery by the use of hospital IT solutions."

Buddrus adds: "Radboudumc is also the first fully approved member of the HIMSS Stage 6 & 7 Club, and expected to take a leading role in providing continuous evidence of the benefits of IT. Among the many highlights of Radboudumc's achievements since its last evaluation and recognition as Stage 6, I'd like to emphasize their approach towards medication safety, as well as Clinical Decision Support."

For more information on the stage 7 award visit http://himssanalytics.eu/emram/

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About Radboud university medical centre
Radboud university medical center founded in 1951, is an institute for patient care, research and education & training, located in Nijmegen in the Netherlands. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. We offer excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...